Grail is reportedly considering squeezing in another $1 billion in funding before going public in Hong Kong this year, according to Bloomberg.

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

The Sofinnova-led round will support trials of LimFlow's device, which diverts blood around diseased arteries to save patients and their limbs.

Medical Microinstruments captured €20 million ($24.5 million) in series A financing it will use to develop a robotic system for microsurgery.

Novocure wants to bring the electric field device to market in mesothelioma via the rarely used humanitarian device exemption.

FDA officials developed the strategy to address the emerging cybersecurity threat and to incentivize device designers to focus on safety innovations.

The partners will use Illumina’s NGS capabilities to create IVDs that assess tumor mutation burden and other potentially predictive biomarkers.

The cash sets Intact up to advance a clinical development program designed to generate data to support FDA approval of the Tack Endovascular System.

The investment sets the Kite Pharma-partnered firm up to refine software to orchestrate the many steps involved in the production of cell therapies.

Boston Scientific will pay up to $275 million to acquire nVision Medical, the developer of a device used for early detection of ovarian cancer.